Security key
396879108
- Security type / class
- Equity / COM
- Total 13F shares
- 1,327,035
- Total 13F value
- $27,880,174
- Share change
- +112,136
- SEC-reported price per share
- $21.01
- Number of holders
- 49
- Value change
- +$3,310,098
- Number of buys
- 22
- Number of sells
- 25
Report period
Q4 2025
Institutions
49
Top holders
10
GLSI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Greenwich LifeSciences, Inc. SEC filings
Greenwich LifeSciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 396879108
Recent filing periods:
Ownership snapshot
Top reported holders of GLSI - Greenwich LifeSciences, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
0/15
Latest evidence
30 Sep 2025
13F
3/4/5
Highest disclosed value: $3,614,825
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. has the largest disclosed position value at $3.61M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Disclosed position value
Top 5
BlackRock, Inc.
$3.61M
Jaye Thompson
$3.41M
VANGUARD GROUP INC
$2.81M
GEODE CAPITAL MANAGEMENT, LLC
$1.41M
STATE STREET CORP
$815.4K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
Company
|
—
class O/S missing
|
$3,614,825
363,299 shares
|
— | 30 Sep 2025 |
| Jaye Thompson |
3/4/5
VP Clinical Reg Affairs
|
—
mixed-class rows
|
$3,410,151
563,784 shares
mixed-class rows
|
— | 24 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$2,807,700
282,181 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$1,414,205
142,116 shares
|
— | 30 Sep 2025 |
| STATE STREET CORP |
13F
Company
|
—
class O/S missing
|
$815,363
81,946 shares
|
— | 30 Sep 2025 |
| NORTHERN TRUST CORP |
13F
Company
|
—
class O/S missing
|
$755,255
75,905 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
49
Shares
1,327,035
Rows available
49
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
51
Q4 2025 holders
49
Holder diff
-2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend